Clearside Biomedical, Inc. (CLSD) has an overall financial health rating of B- with a composite score of 0 out of 5.
This suggests the company faces some financial challenges worth monitoring. Rating as of 2026-03-02.
| Date | Rating | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-03-02 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-11-28 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-11-26 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-11-25 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-11-24 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-11-21 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-11-20 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-11-19 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-11-18 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-11-17 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-11-14 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-11-13 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 |
